Skip to content

Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR

by GE Medical Systems SCS

510(k) K232344Ref 5874604Model Allia

Active European Union and United States. Also listed in GUDID (US).

CE MDR 510(k)

Valid until

Not listed

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

12 ongoing

This device is named in the recall

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, FDA 510(k), GUDID, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Special NumberK232344 Date11 Oct 2023ClearedStatusActive
United StatesGUDID listing GUDID Number00195278485168 UDI-DI Date8 Apr 2022ListedStatusListed GUDID: in commercial distribution
European UnionCE/MDR EUDAMED Number8406821BUG00099HR Basic UDI-DI 00195278485168UDI-DIDate4 Mar 2022RegisteredStatusActive

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Recalls

13 recalls · 12 ongoing · FDA

  • 4 recalls, same reason

    • Ongoing Z-2314-2026 FDA Class II initiated 20 Apr 2026
    • Ongoing Z-2317-2026 FDA Class II initiated 20 Apr 2026
    • Ongoing Z-2315-2026 FDA Class II initiated 20 Apr 2026
    • Ongoing Z-2316-2026 FDA Class II initiated 20 Apr 2026

    GE HealthCare has become aware of a potential issue affecting an electrical cable on certain IGS systems equipped with Gaia generators. This issue could lead to a risk of electrical shock to service personnel performing installation, maintenance, or troubleshooting activities inside the C-FRT cabinet while power is ON.

  • 7 recalls, same reason

    • Ongoing Z-1779-2024 FDA Class II initiated 18 Mar 2024
    • Ongoing Z-1780-2024 FDA Class II initiated 18 Mar 2024
    • Ongoing Z-1777-2024 FDA Class II initiated 18 Mar 2024
    • Ongoing Z-1783-2024 FDA Class II initiated 18 Mar 2024
    • Ongoing Z-1778-2024 FDA Class II initiated 18 Mar 2024
    • Ongoing Z-1781-2024 FDA Class II initiated 18 Mar 2024
    • Ongoing Z-1782-2024 FDA Class II initiated 18 Mar 2024

    GE HealthCare has become aware of the potential that adhesive material might not have been applied to some bolts of certain Innova IGS, Discovery IGS, Interact IGS, Allia IGS and Allia Pulse IGS products. This could result in a potential fall of the Detector/Elevator or X-ray tube of the frontal Gantry assembly.

    • Ongoing Z-1201-2019 FDA Class II initiated 15 Mar 2019

    There is a potential for loss of the x-ray imaging function when the user changes field of view (FOV) from 30cm to 20cm or from 20cm to 30cm while releasing the fluoroscopy footswitch pedal simultaneously.

    • Terminated Z-1864-2021 FDA Class II initiated 19 Apr 2021

    The IGS system can experience a single vertical line defect where the vertical line divides and horizontally shifts live monitor images into two unequal image parts within the monitor display screen.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k) · GUDID

Trade Name
Igs 3 EUDAMED
Allia GUDID
Generic Name
Stationary angiographic x-ray system, digital
Model / Ref / Catalog
Allia, 5874604, IGS 3
Primary DI / UDI-DI
00195278485168
Basic UDI-DI
8406821BUG00099HR
510(k) Number
FDA Product Code
OWB, JAA, IZI
EMDN Code
Z11030102 Stationary angiography systems for angiographic and cardiologic studies
GMDN Term
Stationary angiographic x-ray system, digital
Device Class
Class IIb EUDAMED
Class II 510(k)GUDID
Regulation
21 CFR Part 892.1650 510(k)GUDID
892.1600 GUDID
EU market of registration
Poland
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent
GUDID distribution status
In Commercial Distribution

Truth per registry

3 sources · 3 fields differ

FieldEUDAMED510(k)GUDID
Model / ReferenceEUDAMED
Allia
5874604
510(k)
—
GUDID
IGS 3
510(k) NumberEUDAMED
—
510(k)
K232344
GUDID
K181403
Device ClassEUDAMED
Class IIb
510(k)
Class II
GUDID
Class II

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Allia IGS 3, Allia IGS 5, Allia IGS 7, and Allia IGS 7 OR are interventional fluoroscopic X-ray systems designed for real-time imaging during minimally invasive procedures. These devices provide high-resolution, low-dose fluoroscopy to guide interventions such as vascular access, orthopedic fixation, and electrophysiology studies, enhancing precision and reducing patient exposure to radiation.

These systems are supplied as reusable medical equipment, intended for use in radiology departments and operating rooms. They are classified as Class II devices under FDA regulations and comply with the Medical Device Regulation (MDR) in the EU. The Allia IGS series includes multiple image intensifier sizes (3, 5, 7 inches) and an optional OR model, with MRI safety ratings specified per model. Sterilization and maintenance protocols are manufacturer-defined, and regulatory authorizations include FDA 510(k) clearance and MDR compliance.

Other devices from GE Medical Systems SCS

See all devices from GE Medical Systems SCS →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of procedures can the Allia IGS systems support with their real-time imaging capabilities?

    The Allia IGS systems are designed for real-time fluoroscopic imaging to guide minimally invasive procedures such as vascular access, orthopedic fixation, and electrophysiology studies. Their high-resolution, low-dose imaging helps enhance precision during interventions, reducing patient radiation exposure while supporting a wide range of interventional radiology and surgical applications.

  • Are the Allia IGS systems reusable, and if so, what maintenance or sterilization protocols should be followed?

    Yes, the Allia IGS systems are supplied as reusable medical equipment. Maintenance and sterilization protocols are manufacturer-defined, meaning GE Medical Systems SCS provides specific guidelines for cleaning, disinfection, and servicing to ensure proper functionality and safety. Always follow the manufacturer’s instructions to maintain compliance and performance.

  • What are the key differences between the Allia IGS 3, 5, 7, and 7 OR models, particularly in terms of image intensifier size and intended use?

    The Allia IGS series varies by image intensifier size: the 3, 5, and 7 refer to the diameter of the intensifier in inches, which affects field of view and imaging flexibility. The Allia IGS 7 OR model is specifically designed for operating room use, likely incorporating additional features or MRI safety ratings tailored for surgical environments. The size selection helps clinicians match the system to procedural needs, such as smaller fields for precise vascular work or larger fields for broader anatomical coverage.

  • How is the regulatory status of the Allia IGS systems defined, and what does this mean for purchasing or clinical use?

    The Allia IGS systems hold FDA 510(k) clearance and comply with the EU Medical Device Regulation (MDR), confirming they meet U.S. and European safety and performance standards. This means they are classified as Class II devices under FDA regulations, indicating a moderate risk level that requires compliance with specific controls. For purchasing or clinical use, this ensures the systems undergo rigorous validation but does not imply any specific clinical indication—only that they are authorized for interventional fluoroscopy as described.

  • What should buyers consider when selecting between the Allia IGS models for their facility, particularly regarding MRI compatibility?

    Buyers should verify the MRI safety ratings for each model, as the Allia IGS series includes variations with different compatibility levels for MRI environments. While the base models (3, 5, 7) are designed for radiology departments, the Allia IGS 7 OR may offer enhanced MRI safety features for hybrid ORs or facilities requiring seamless integration with MRI systems. Always confirm the specific MRI safety documentation provided by GE Medical Systems SCS to ensure compatibility with your facility’s workflow.

Properties

  • Prescription Use
  • Serial Number

Other properties (22)

  • Sterile: No
  • Single Use: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No
  • Over-the-Counter: No
  • Convenience Kit: No
  • Combination Product: No
  • HCT/P: No
  • Premarket Exempt: No
  • Lot / Batch Number: No
  • Expiration Date: No
  • Manufacturing Date: No